Evidence map›Paper›PMID 33573095›Full record

ArticleInternational journal of molecular sciences2021

Prominent Indomethacin-Induced Enteropathy in Fcgriib

Thansita Bhunyakarnjanarat, Kanyarat Udompornpitak, Wilasinee Saisorn, Bhumdhanin Chantraprapawat, Peerapat Visitchanakun, Cong Phi Dang, Jiraphorn Issara-Amphorn, Asada Leelahavanichkul

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
2.5field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 37 citations in OpenAlex.

  1. Article
  2. Article
  3. Accelerating and protective effects toward cancer growth in cGAS and FcgRIIb deficient mice, respectively, an impact of macrophage polarization.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2025
    Article
  4. Review
  5. Syk inhibitor attenuates lupus in FcγRIIbCell death discovery · 2025
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Frontiers in immunology · 2023
    Article
  12. International journal of molecular sciences · 2022
    Article
  13. Article
  14. Beta-Glucan fromInternational journal of molecular sciences · 2022
    Article
  15. Review
  16. Article
  17. Uremia-Induced Gut Barrier Defect in 5/6 Nephrectomized Mice Is Worsened byInternational journal of molecular sciences · 2022
    Article
  18. Article
  19. Review
  20. Nutrients · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Thansita BhunyakarnjanaratMedical Microbiology, Interdisciplinary and International Program, Graduate School, Chulalongkorn University, Bangkok 10330, Thailand.
Kanyarat UdompornpitakTranslational Research in Inflammation and Immunology Research Unit (TRIRU), Department of Microbiology, Chulalongkorn University, Bangkok 10330, Thailand.
Wilasinee SaisornTranslational Research in Inflammation and Immunology Research Unit (TRIRU), Department of Microbiology, Chulalongkorn University, Bangkok 10330, Thailand.ORCID 0000-0002-0074-0389
Bhumdhanin ChantraprapawatTranslational Research in Inflammation and Immunology Research Unit (TRIRU), Department of Microbiology, Chulalongkorn University, Bangkok 10330, Thailand.
Peerapat VisitchanakunTranslational Research in Inflammation and Immunology Research Unit (TRIRU), Department of Microbiology, Chulalongkorn University, Bangkok 10330, Thailand.
Cong Phi DangTranslational Research in Inflammation and Immunology Research Unit (TRIRU), Department of Microbiology, Chulalongkorn University, Bangkok 10330, Thailand.
Jiraphorn Issara-AmphornTranslational Research in Inflammation and Immunology Research Unit (TRIRU), Department of Microbiology, Chulalongkorn University, Bangkok 10330, Thailand.
Asada LeelahavanichkulDepartment of Microbiology, Faculty of Medicine, Chulalongkorn University, Bangkok 10330, Thailand.
Chulalongkorn University · TH

Funding

the Program Management Unit for Human Resources & Institutional Development Research and Innovation-CU Flagship B05F630073the Program Management Unit for Human Resources & Institutional Development Research and Innovation-CU Global Partnership B16F630071the Ratchadapisek Sompoch and Graduate school CU_GR_63_108_3
6 · The paper itself

Abstract

A high dose of NSAIDs, a common analgesic, might induce lupus activity through several NSAIDs adverse effects including gastrointestinal permeability defect (gut leakage) and endotoxemia. Indomethacin (25 mg/day) was orally administered for 7 days in 24-wk-old Fc gamma receptor IIb deficient (FcgRIIb-/-) mice, an asymptomatic lupus model (increased anti-dsDNA without lupus nephritis), and age-matched wild-type (WT) mice. Severity of indomethacin-induced enteropathy in FcgRIIb-/- mice was higher than WT mice as demonstrated by survival analysis, intestinal injury (histology, immune-deposition, and intestinal cytokines), gut leakage (FITC-dextran assay and endotoxemia), serum cytokines, and lupus characteristics (anti-dsDNA, renal injury, and proteinuria). Prominent responses of FcgRIIb-/- macrophages toward lipopolysaccharide (LPS) compared to WT cells due to the expression of only activating-FcgRs without inhibitory-

Indexed as

AnimalsAnti-Inflammatory Agents, Non-SteroidalDisease Models, AnimalEndotoxemiaEnterocolitisFemaleGene DeletionIndomethacinLupus Erythematosus, SystemicMacrophage ActivationMacrophagesMiceMice, Inbred C57BLReceptors, IgGAnti-Inflammatory Agents, Non-SteroidalFcgr2b protein, mouseIndomethacinReceptors, IgGFcgRIIb deficient micegut leakageNSAIDs-enteropathysystemic lupus erythematosus

Identifiers

PMID33573095
PMCPMC7866536
OpenAlexW3126163214

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.